nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—Cholangitis—Thalidomide—leprosy	0.0265	0.0311	CcSEcCtD
Ribavirin—Glucosamine—IFNG—leprosy	0.0244	0.705	CrCbGaD
Ribavirin—Mood alteration NOS—Thalidomide—leprosy	0.0229	0.0269	CcSEcCtD
Ribavirin—Nephrotic syndrome—Dapsone—leprosy	0.0186	0.0218	CcSEcCtD
Ribavirin—Enuresis—Thalidomide—leprosy	0.0161	0.0189	CcSEcCtD
Ribavirin—Suicide attempt—Dapsone—leprosy	0.0158	0.0186	CcSEcCtD
Ribavirin—Lipase increased—Thalidomide—leprosy	0.0156	0.0184	CcSEcCtD
Ribavirin—ENPP1—skin of body—leprosy	0.0144	0.126	CbGeAlD
Ribavirin—Polyneuropathy—Thalidomide—leprosy	0.0141	0.0166	CcSEcCtD
Ribavirin—ENPP1—tendon—leprosy	0.011	0.0959	CbGeAlD
Ribavirin—Pericarditis—Thalidomide—leprosy	0.0106	0.0125	CcSEcCtD
Ribavirin—Lacrimal disorder—Thalidomide—leprosy	0.0103	0.0121	CcSEcCtD
Ribavirin—Proteinuria—Dapsone—leprosy	0.0102	0.012	CcSEcCtD
Ribavirin—Glucosamine—TNF—leprosy	0.0102	0.295	CrCbGaD
Ribavirin—Protein urine present—Dapsone—leprosy	0.0101	0.0118	CcSEcCtD
Ribavirin—IMPDH1—eye—leprosy	0.00983	0.0858	CbGeAlD
Ribavirin—Aphthous stomatitis—Thalidomide—leprosy	0.00979	0.0115	CcSEcCtD
Ribavirin—Cerebral ischaemia—Thalidomide—leprosy	0.0095	0.0112	CcSEcCtD
Ribavirin—ENPP1—testis—leprosy	0.00909	0.0794	CbGeAlD
Ribavirin—Lymphopenia—Thalidomide—leprosy	0.00897	0.0105	CcSEcCtD
Ribavirin—Skin exfoliation—Dapsone—leprosy	0.00856	0.0101	CcSEcCtD
Ribavirin—Sexual dysfunction—Thalidomide—leprosy	0.00819	0.00963	CcSEcCtD
Ribavirin—Suicide attempt—Thalidomide—leprosy	0.00809	0.00951	CcSEcCtD
Ribavirin—NT5C2—tendon—leprosy	0.00802	0.07	CbGeAlD
Ribavirin—Toothache—Thalidomide—leprosy	0.00755	0.00887	CcSEcCtD
Ribavirin—Psoriasis—Thalidomide—leprosy	0.00731	0.00859	CcSEcCtD
Ribavirin—Oral candidiasis—Thalidomide—leprosy	0.00723	0.00849	CcSEcCtD
Ribavirin—Hypothyroidism—Thalidomide—leprosy	0.00715	0.00841	CcSEcCtD
Ribavirin—Tooth disorder—Thalidomide—leprosy	0.00708	0.00832	CcSEcCtD
Ribavirin—Nail disorder—Thalidomide—leprosy	0.00708	0.00832	CcSEcCtD
Ribavirin—ADK—skin of body—leprosy	0.00674	0.0589	CbGeAlD
Ribavirin—Menstrual disorder—Thalidomide—leprosy	0.00674	0.00792	CcSEcCtD
Ribavirin—NT5C2—testis—leprosy	0.00664	0.058	CbGeAlD
Ribavirin—Neuralgia—Thalidomide—leprosy	0.00661	0.00777	CcSEcCtD
Ribavirin—NT5C2—nervous system—leprosy	0.00651	0.0569	CbGeAlD
Ribavirin—IMPDH1—tendon—leprosy	0.00651	0.0569	CbGeAlD
Ribavirin—Hepatomegaly—Thalidomide—leprosy	0.00649	0.00762	CcSEcCtD
Ribavirin—Cyanosis—Thalidomide—leprosy	0.00649	0.00762	CcSEcCtD
Ribavirin—Interstitial lung disease—Thalidomide—leprosy	0.00649	0.00762	CcSEcCtD
Ribavirin—Psychotic disorder—Dapsone—leprosy	0.00636	0.00747	CcSEcCtD
Ribavirin—Hyperaesthesia—Thalidomide—leprosy	0.00585	0.00688	CcSEcCtD
Ribavirin—Nasopharyngitis—Dapsone—leprosy	0.00582	0.00684	CcSEcCtD
Ribavirin—Muscular weakness—Dapsone—leprosy	0.00574	0.00675	CcSEcCtD
Ribavirin—Myocardial ischaemia—Thalidomide—leprosy	0.00571	0.00671	CcSEcCtD
Ribavirin—Influenza—Dapsone—leprosy	0.00563	0.00661	CcSEcCtD
Ribavirin—Endocrine disorder—Thalidomide—leprosy	0.00554	0.00651	CcSEcCtD
Ribavirin—Pancreatitis—Dapsone—leprosy	0.00552	0.00648	CcSEcCtD
Ribavirin—Blood disorder—Thalidomide—leprosy	0.0055	0.00646	CcSEcCtD
Ribavirin—Apnoea—Thalidomide—leprosy	0.00542	0.00637	CcSEcCtD
Ribavirin—IMPDH1—testis—leprosy	0.00539	0.0471	CbGeAlD
Ribavirin—IMPDH1—nervous system—leprosy	0.00529	0.0462	CbGeAlD
Ribavirin—Proteinuria—Thalidomide—leprosy	0.00523	0.00614	CcSEcCtD
Ribavirin—Amenorrhoea—Thalidomide—leprosy	0.00523	0.00614	CcSEcCtD
Ribavirin—Protein urine present—Thalidomide—leprosy	0.00515	0.00606	CcSEcCtD
Ribavirin—Photosensitivity reaction—Dapsone—leprosy	0.00514	0.00604	CcSEcCtD
Ribavirin—ADK—tendon—leprosy	0.00513	0.0448	CbGeAlD
Ribavirin—Viral infection—Thalidomide—leprosy	0.00508	0.00597	CcSEcCtD
Ribavirin—Skin discolouration—Thalidomide—leprosy	0.00508	0.00597	CcSEcCtD
Ribavirin—Bone disorder—Thalidomide—leprosy	0.00508	0.00597	CcSEcCtD
Ribavirin—Hyperbilirubinaemia—Thalidomide—leprosy	0.00505	0.00593	CcSEcCtD
Ribavirin—Cellulitis—Thalidomide—leprosy	0.00505	0.00593	CcSEcCtD
Ribavirin—Hypocalcaemia—Thalidomide—leprosy	0.00502	0.00589	CcSEcCtD
Ribavirin—Herpes simplex—Thalidomide—leprosy	0.00498	0.00586	CcSEcCtD
Ribavirin—Hyperuricaemia—Thalidomide—leprosy	0.00495	0.00582	CcSEcCtD
Ribavirin—Neuropathy peripheral—Dapsone—leprosy	0.00492	0.00578	CcSEcCtD
Ribavirin—Hearing impaired—Thalidomide—leprosy	0.00482	0.00567	CcSEcCtD
Ribavirin—Bone pain—Thalidomide—leprosy	0.00479	0.00563	CcSEcCtD
Ribavirin—Sinusitis—Dapsone—leprosy	0.00471	0.00553	CcSEcCtD
Ribavirin—Blood uric acid increased—Thalidomide—leprosy	0.00468	0.0055	CcSEcCtD
Ribavirin—Pulmonary embolism—Thalidomide—leprosy	0.00459	0.0054	CcSEcCtD
Ribavirin—Pharyngitis—Dapsone—leprosy	0.00447	0.00525	CcSEcCtD
Ribavirin—Colitis—Thalidomide—leprosy	0.00441	0.00518	CcSEcCtD
Ribavirin—Skin exfoliation—Thalidomide—leprosy	0.00438	0.00515	CcSEcCtD
Ribavirin—Candida infection—Thalidomide—leprosy	0.00438	0.00515	CcSEcCtD
Ribavirin—SLC29A1—tendon—leprosy	0.00437	0.0382	CbGeAlD
Ribavirin—Neuropathy—Thalidomide—leprosy	0.00431	0.00507	CcSEcCtD
Ribavirin—Aplastic anaemia—Thalidomide—leprosy	0.00431	0.00507	CcSEcCtD
Ribavirin—ADK—testis—leprosy	0.00425	0.0371	CbGeAlD
Ribavirin—Dry eye—Thalidomide—leprosy	0.00424	0.00498	CcSEcCtD
Ribavirin—Tinnitus—Dapsone—leprosy	0.0042	0.00494	CcSEcCtD
Ribavirin—Rash maculo-papular—Thalidomide—leprosy	0.00417	0.0049	CcSEcCtD
Ribavirin—ADK—nervous system—leprosy	0.00417	0.0364	CbGeAlD
Ribavirin—Pulmonary oedema—Thalidomide—leprosy	0.00409	0.0048	CcSEcCtD
Ribavirin—Hypertonia—Thalidomide—leprosy	0.00403	0.00473	CcSEcCtD
Ribavirin—Hyperkinesia—Thalidomide—leprosy	0.004	0.00471	CcSEcCtD
Ribavirin—Mental disability—Thalidomide—leprosy	0.00398	0.00468	CcSEcCtD
Ribavirin—Sepsis—Thalidomide—leprosy	0.00398	0.00468	CcSEcCtD
Ribavirin—Erythema—Dapsone—leprosy	0.00392	0.00461	CcSEcCtD
Ribavirin—Lymphadenopathy—Thalidomide—leprosy	0.00391	0.00459	CcSEcCtD
Ribavirin—Diabetes mellitus—Thalidomide—leprosy	0.00383	0.0045	CcSEcCtD
Ribavirin—Gastroenteritis—Thalidomide—leprosy	0.00376	0.00442	CcSEcCtD
Ribavirin—Deafness—Thalidomide—leprosy	0.00373	0.00438	CcSEcCtD
Ribavirin—Eczema—Thalidomide—leprosy	0.00371	0.00436	CcSEcCtD
Ribavirin—Vision blurred—Dapsone—leprosy	0.0037	0.00434	CcSEcCtD
Ribavirin—Eye pain—Thalidomide—leprosy	0.00369	0.00434	CcSEcCtD
Ribavirin—SLC29A1—testis—leprosy	0.00362	0.0316	CbGeAlD
Ribavirin—Libido decreased—Thalidomide—leprosy	0.00359	0.00422	CcSEcCtD
Ribavirin—SLC29A1—nervous system—leprosy	0.00355	0.031	CbGeAlD
Ribavirin—Amnesia—Thalidomide—leprosy	0.00355	0.00417	CcSEcCtD
Ribavirin—Increased appetite—Thalidomide—leprosy	0.00355	0.00417	CcSEcCtD
Ribavirin—Vertigo—Dapsone—leprosy	0.00352	0.00414	CcSEcCtD
Ribavirin—Visual disturbance—Thalidomide—leprosy	0.00352	0.00413	CcSEcCtD
Ribavirin—Purpura—Thalidomide—leprosy	0.00346	0.00406	CcSEcCtD
Ribavirin—Arthritis—Thalidomide—leprosy	0.00343	0.00403	CcSEcCtD
Ribavirin—Cough—Dapsone—leprosy	0.00342	0.00402	CcSEcCtD
Ribavirin—Lethargy—Thalidomide—leprosy	0.0034	0.004	CcSEcCtD
Ribavirin—Pain in extremity—Thalidomide—leprosy	0.00333	0.00392	CcSEcCtD
Ribavirin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00333	0.00392	CcSEcCtD
Ribavirin—Disturbance in sexual arousal—Thalidomide—leprosy	0.00331	0.00389	CcSEcCtD
Ribavirin—Migraine—Thalidomide—leprosy	0.00328	0.00386	CcSEcCtD
Ribavirin—Affect lability—Thalidomide—leprosy	0.00328	0.00386	CcSEcCtD
Ribavirin—Psychotic disorder—Thalidomide—leprosy	0.00326	0.00383	CcSEcCtD
Ribavirin—Face oedema—Thalidomide—leprosy	0.00322	0.00378	CcSEcCtD
Ribavirin—Cardiac arrest—Thalidomide—leprosy	0.00317	0.00372	CcSEcCtD
Ribavirin—Mood swings—Thalidomide—leprosy	0.00316	0.00371	CcSEcCtD
Ribavirin—Ataxia—Thalidomide—leprosy	0.00313	0.00368	CcSEcCtD
Ribavirin—Tachycardia—Dapsone—leprosy	0.00312	0.00367	CcSEcCtD
Ribavirin—Dehydration—Thalidomide—leprosy	0.0031	0.00364	CcSEcCtD
Ribavirin—Dry skin—Thalidomide—leprosy	0.00306	0.00359	CcSEcCtD
Ribavirin—Breast disorder—Thalidomide—leprosy	0.00301	0.00354	CcSEcCtD
Ribavirin—Toxic epidermal necrolysis—Thalidomide—leprosy	0.003	0.00353	CcSEcCtD
Ribavirin—Muscular weakness—Thalidomide—leprosy	0.00294	0.00345	CcSEcCtD
Ribavirin—Abdominal distension—Thalidomide—leprosy	0.0029	0.00341	CcSEcCtD
Ribavirin—Insomnia—Dapsone—leprosy	0.00289	0.0034	CcSEcCtD
Ribavirin—Influenza—Thalidomide—leprosy	0.00288	0.00339	CcSEcCtD
Ribavirin—Bronchospasm—Thalidomide—leprosy	0.00283	0.00333	CcSEcCtD
Ribavirin—Pancreatitis—Thalidomide—leprosy	0.00282	0.00332	CcSEcCtD
Ribavirin—Angina pectoris—Thalidomide—leprosy	0.00281	0.0033	CcSEcCtD
Ribavirin—Bronchitis—Thalidomide—leprosy	0.00277	0.00326	CcSEcCtD
Ribavirin—Neutropenia—Thalidomide—leprosy	0.00269	0.00317	CcSEcCtD
Ribavirin—Upper respiratory tract infection—Thalidomide—leprosy	0.00268	0.00315	CcSEcCtD
Ribavirin—Pollakiuria—Thalidomide—leprosy	0.00266	0.00313	CcSEcCtD
Ribavirin—Erectile dysfunction—Thalidomide—leprosy	0.00265	0.00312	CcSEcCtD
Ribavirin—Photosensitivity reaction—Thalidomide—leprosy	0.00263	0.00309	CcSEcCtD
Ribavirin—Weight increased—Thalidomide—leprosy	0.00262	0.00308	CcSEcCtD
Ribavirin—Gastrointestinal pain—Dapsone—leprosy	0.00262	0.00308	CcSEcCtD
Ribavirin—Weight decreased—Thalidomide—leprosy	0.00261	0.00306	CcSEcCtD
Ribavirin—Hyperglycaemia—Thalidomide—leprosy	0.0026	0.00305	CcSEcCtD
Ribavirin—Pneumonia—Thalidomide—leprosy	0.00258	0.00304	CcSEcCtD
Ribavirin—Infestation—Thalidomide—leprosy	0.00257	0.00302	CcSEcCtD
Ribavirin—Infestation NOS—Thalidomide—leprosy	0.00257	0.00302	CcSEcCtD
Ribavirin—Depression—Thalidomide—leprosy	0.00256	0.00301	CcSEcCtD
Ribavirin—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00255	0.00299	CcSEcCtD
Ribavirin—Acute coronary syndrome—Thalidomide—leprosy	0.00253	0.00298	CcSEcCtD
Ribavirin—Body temperature increased—Dapsone—leprosy	0.00253	0.00297	CcSEcCtD
Ribavirin—Abdominal pain—Dapsone—leprosy	0.00253	0.00297	CcSEcCtD
Ribavirin—Renal failure—Thalidomide—leprosy	0.00253	0.00297	CcSEcCtD
Ribavirin—Myocardial infarction—Thalidomide—leprosy	0.00252	0.00296	CcSEcCtD
Ribavirin—Neuropathy peripheral—Thalidomide—leprosy	0.00252	0.00296	CcSEcCtD
Ribavirin—Stomatitis—Thalidomide—leprosy	0.0025	0.00294	CcSEcCtD
Ribavirin—Conjunctivitis—Thalidomide—leprosy	0.0025	0.00293	CcSEcCtD
Ribavirin—Epistaxis—Thalidomide—leprosy	0.00242	0.00285	CcSEcCtD
Ribavirin—Sinusitis—Thalidomide—leprosy	0.00241	0.00283	CcSEcCtD
Ribavirin—Bradycardia—Thalidomide—leprosy	0.00235	0.00276	CcSEcCtD
Ribavirin—Rhinitis—Thalidomide—leprosy	0.00231	0.00272	CcSEcCtD
Ribavirin—Hepatitis—Thalidomide—leprosy	0.00231	0.00271	CcSEcCtD
Ribavirin—Hypoaesthesia—Thalidomide—leprosy	0.00229	0.0027	CcSEcCtD
Ribavirin—Pharyngitis—Thalidomide—leprosy	0.00229	0.00269	CcSEcCtD
Ribavirin—Urinary tract disorder—Thalidomide—leprosy	0.00228	0.00268	CcSEcCtD
Ribavirin—Oedema peripheral—Thalidomide—leprosy	0.00227	0.00267	CcSEcCtD
Ribavirin—Urethral disorder—Thalidomide—leprosy	0.00226	0.00266	CcSEcCtD
Ribavirin—Visual impairment—Thalidomide—leprosy	0.00222	0.00261	CcSEcCtD
Ribavirin—Erythema multiforme—Thalidomide—leprosy	0.00218	0.00256	CcSEcCtD
Ribavirin—Eye disorder—Thalidomide—leprosy	0.00216	0.00253	CcSEcCtD
Ribavirin—Tinnitus—Thalidomide—leprosy	0.00215	0.00253	CcSEcCtD
Ribavirin—Cardiac disorder—Thalidomide—leprosy	0.00214	0.00252	CcSEcCtD
Ribavirin—Angiopathy—Thalidomide—leprosy	0.00209	0.00246	CcSEcCtD
Ribavirin—Immune system disorder—Thalidomide—leprosy	0.00208	0.00245	CcSEcCtD
Ribavirin—Mediastinal disorder—Thalidomide—leprosy	0.00208	0.00244	CcSEcCtD
Ribavirin—Chills—Thalidomide—leprosy	0.00207	0.00243	CcSEcCtD
Ribavirin—Arrhythmia—Thalidomide—leprosy	0.00206	0.00242	CcSEcCtD
Ribavirin—Alopecia—Thalidomide—leprosy	0.00204	0.00239	CcSEcCtD
Ribavirin—Vomiting—Dapsone—leprosy	0.00203	0.00239	CcSEcCtD
Ribavirin—Mental disorder—Thalidomide—leprosy	0.00202	0.00237	CcSEcCtD
Ribavirin—Malnutrition—Thalidomide—leprosy	0.00201	0.00236	CcSEcCtD
Ribavirin—Headache—Dapsone—leprosy	0.002	0.00236	CcSEcCtD
Ribavirin—Flatulence—Thalidomide—leprosy	0.00198	0.00232	CcSEcCtD
Ribavirin—Tension—Thalidomide—leprosy	0.00197	0.00231	CcSEcCtD
Ribavirin—Dysgeusia—Thalidomide—leprosy	0.00197	0.00231	CcSEcCtD
Ribavirin—Nervousness—Thalidomide—leprosy	0.00195	0.00229	CcSEcCtD
Ribavirin—Back pain—Thalidomide—leprosy	0.00194	0.00228	CcSEcCtD
Ribavirin—Muscle spasms—Thalidomide—leprosy	0.00193	0.00227	CcSEcCtD
Ribavirin—Nausea—Dapsone—leprosy	0.0019	0.00223	CcSEcCtD
Ribavirin—Vision blurred—Thalidomide—leprosy	0.00189	0.00222	CcSEcCtD
Ribavirin—Tremor—Thalidomide—leprosy	0.00188	0.00221	CcSEcCtD
Ribavirin—Ill-defined disorder—Thalidomide—leprosy	0.00186	0.00219	CcSEcCtD
Ribavirin—Anaemia—Thalidomide—leprosy	0.00186	0.00218	CcSEcCtD
Ribavirin—Agitation—Thalidomide—leprosy	0.00184	0.00217	CcSEcCtD
Ribavirin—Angioedema—Thalidomide—leprosy	0.00183	0.00216	CcSEcCtD
Ribavirin—Malaise—Thalidomide—leprosy	0.00181	0.00213	CcSEcCtD
Ribavirin—Vertigo—Thalidomide—leprosy	0.0018	0.00212	CcSEcCtD
Ribavirin—Syncope—Thalidomide—leprosy	0.0018	0.00212	CcSEcCtD
Ribavirin—Leukopenia—Thalidomide—leprosy	0.0018	0.00211	CcSEcCtD
Ribavirin—Palpitations—Thalidomide—leprosy	0.00177	0.00208	CcSEcCtD
Ribavirin—Loss of consciousness—Thalidomide—leprosy	0.00176	0.00207	CcSEcCtD
Ribavirin—Cough—Thalidomide—leprosy	0.00175	0.00206	CcSEcCtD
Ribavirin—Convulsion—Thalidomide—leprosy	0.00174	0.00204	CcSEcCtD
Ribavirin—Hypertension—Thalidomide—leprosy	0.00173	0.00204	CcSEcCtD
Ribavirin—Arthralgia—Thalidomide—leprosy	0.00171	0.00201	CcSEcCtD
Ribavirin—Chest pain—Thalidomide—leprosy	0.00171	0.00201	CcSEcCtD
Ribavirin—Myalgia—Thalidomide—leprosy	0.00171	0.00201	CcSEcCtD
Ribavirin—Anxiety—Thalidomide—leprosy	0.0017	0.002	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.0017	0.00199	CcSEcCtD
Ribavirin—Discomfort—Thalidomide—leprosy	0.00169	0.00198	CcSEcCtD
Ribavirin—Dry mouth—Thalidomide—leprosy	0.00167	0.00196	CcSEcCtD
Ribavirin—Confusional state—Thalidomide—leprosy	0.00165	0.00194	CcSEcCtD
Ribavirin—Oedema—Thalidomide—leprosy	0.00164	0.00193	CcSEcCtD
Ribavirin—Shock—Thalidomide—leprosy	0.00161	0.00189	CcSEcCtD
Ribavirin—Nervous system disorder—Thalidomide—leprosy	0.00161	0.00189	CcSEcCtD
Ribavirin—Thrombocytopenia—Thalidomide—leprosy	0.0016	0.00189	CcSEcCtD
Ribavirin—Tachycardia—Thalidomide—leprosy	0.0016	0.00188	CcSEcCtD
Ribavirin—Skin disorder—Thalidomide—leprosy	0.00159	0.00187	CcSEcCtD
Ribavirin—Hyperhidrosis—Thalidomide—leprosy	0.00158	0.00186	CcSEcCtD
Ribavirin—Anorexia—Thalidomide—leprosy	0.00156	0.00184	CcSEcCtD
Ribavirin—Hypotension—Thalidomide—leprosy	0.00153	0.0018	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Thalidomide—leprosy	0.00149	0.00175	CcSEcCtD
Ribavirin—Insomnia—Thalidomide—leprosy	0.00148	0.00174	CcSEcCtD
Ribavirin—Paraesthesia—Thalidomide—leprosy	0.00147	0.00173	CcSEcCtD
Ribavirin—Dyspnoea—Thalidomide—leprosy	0.00146	0.00172	CcSEcCtD
Ribavirin—Somnolence—Thalidomide—leprosy	0.00146	0.00171	CcSEcCtD
Ribavirin—Dyspepsia—Thalidomide—leprosy	0.00144	0.00169	CcSEcCtD
Ribavirin—Decreased appetite—Thalidomide—leprosy	0.00142	0.00167	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Thalidomide—leprosy	0.00141	0.00166	CcSEcCtD
Ribavirin—Fatigue—Thalidomide—leprosy	0.00141	0.00166	CcSEcCtD
Ribavirin—Constipation—Thalidomide—leprosy	0.0014	0.00165	CcSEcCtD
Ribavirin—Pain—Thalidomide—leprosy	0.0014	0.00165	CcSEcCtD
Ribavirin—Feeling abnormal—Thalidomide—leprosy	0.00135	0.00159	CcSEcCtD
Ribavirin—Gastrointestinal pain—Thalidomide—leprosy	0.00134	0.00157	CcSEcCtD
Ribavirin—Urticaria—Thalidomide—leprosy	0.0013	0.00153	CcSEcCtD
Ribavirin—Body temperature increased—Thalidomide—leprosy	0.0013	0.00152	CcSEcCtD
Ribavirin—Abdominal pain—Thalidomide—leprosy	0.0013	0.00152	CcSEcCtD
Ribavirin—Hypersensitivity—Thalidomide—leprosy	0.00121	0.00142	CcSEcCtD
Ribavirin—Asthenia—Thalidomide—leprosy	0.00118	0.00138	CcSEcCtD
Ribavirin—Pruritus—Thalidomide—leprosy	0.00116	0.00136	CcSEcCtD
Ribavirin—Diarrhoea—Thalidomide—leprosy	0.00112	0.00132	CcSEcCtD
Ribavirin—Dizziness—Thalidomide—leprosy	0.00108	0.00127	CcSEcCtD
Ribavirin—Vomiting—Thalidomide—leprosy	0.00104	0.00122	CcSEcCtD
Ribavirin—Rash—Thalidomide—leprosy	0.00103	0.00121	CcSEcCtD
Ribavirin—Dermatitis—Thalidomide—leprosy	0.00103	0.00121	CcSEcCtD
Ribavirin—Headache—Thalidomide—leprosy	0.00103	0.00121	CcSEcCtD
Ribavirin—Nausea—Thalidomide—leprosy	0.000973	0.00114	CcSEcCtD
